Decreased DOT1L along with low levels of H3K79me3 is associated with epithelial–mesenchymal transition (EMT) and PDL1 expression, but the effect of DOT1L on tumor immunity is still under investigation [97]. The gene discussed is CD274; the disease is neoplasm.